StockData
Niagen Bioscience, Inc. logo

Niagen Bioscience, Inc. (NAGE) stock

NAGENasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3013% below fair value
$2.01−0.06 (-2.66%)

Close on Nov 16, 2026Market cap $159.04MP/E 16.8Yield –

How the market prices Niagen Bioscience

Each ratio against its own distribution since 2016, from month-end prices and the figures reported at the time

Niagen Bioscience trades at 1.3× its earnings, against a median of 2.4× since 2016 — on the cheap side of its own range.

The shaded bar covers the 5th to 95th percentile of month-end values since 2016, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to sales since 2016

Median 2.4×, today 1.3×

What Niagen Bioscience keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Gross margin63.9%vs 52.9%
Operating margin3.90%vs -42.9%
EBITDA margin3.90%vs -30.2%
Pretax margin9.04%vs -13.0%
Net margin8.37%vs -39.9%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity13.3%vs -53.5%
Return on assets9.90%vs -40.7%
Return on invested capital44.3%vs -33.0%
Return on capital employed5.20%vs -38.7%

How hard the assets work

Revenue per dollar of assets1.18vs 0.39
Inventory turns a year2.25vs 2.68
Revenue per employee$1.05Mvs $405.05K
Profit per employee$87.52Kvs -$704.12K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How fast it is growing

Trailing twelve months against a year earlier, and the compound annual rate over three and five fiscal years

Last 12 months3-year, a year5-year, a yearIndustry median

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by $69.51M. That is 77.6% of the $89.53M it would cost to buy the business outright.

Cash and short-term investments$69.51M
EBITDA, trailing twelve months$4.78M

Leverage and liquidity

Current ratio5.93vs 3.30
Quick ratio4.52vs 2.39

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

3.87
DistressGrey zoneSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

7 of 9 tests passed

Price against two rules of thumb

Graham's number and Lynch's fair value, both derived from current earnings.

Graham $1.68Price $2.01

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield6.44%vs -22.5%
Buyback yield3.38%vs -0.65%
Shareholder yield3.38%vs 0.00%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 16, 2026

$1.9752-week low52-week high$7.12
$2.0120-day50-day200-day

The close sits 1% of the way up the 52-week range, 71.7% below the high.

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

34
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

NAGES&P 500
PeriodNAGES&P 500DifferenceNAGE per yearS&P 500 per year
1 month-19.3%-3.1%−16.2 pts
3 months-33.4%-4.5%−29.0 pts
Year to date-68.4%+9.4%−77.8 pts
1 year-70.7%+11.3%−82.1 pts
3 years+37.7%+70.4%−32.7 pts+11.2%+19.4%
5 years-66.3%+68.6%−134.9 pts-19.6%+11.0%
10 years-23.3%+297.7%−321.0 pts-2.6%+14.8%

How much it moves

Volatility, 1 year50.6%vs 80.4%
Volume against its 90-day average1.41vs 0.86

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

4M NAGE shares were sold short on Oct 30, 2026, up 4.2% from the previous report, or 5.79% of the shares available to trade. At recent volumes it would take 8.9 days to buy them back. Over the last 20 sessions, 51.6% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Short interest as a share of the float5.79%vs 8.91%
Short interest as a share of all shares5.50%vs 6.30%
Days of volume to buy it back8.91vs 5.16

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20264,348,687+4.2%487,9268.9
Oct 15, 20264,175,152+7.8%674,9506.2
Sep 30, 20263,874,102-3.1%392,9849.9
Sep 15, 20263,996,318-3.8%353,83511.3
Aug 31, 20264,155,915-3.6%470,6208.8
Aug 14, 20264,312,635-5.1%805,0855.4
Jul 31, 20264,545,665-5.0%627,5107.2
Jul 15, 20264,786,324+8.9%733,0576.5
Jun 30, 20264,394,606-2.3%789,5565.6
Jun 15, 20264,498,798-4.6%652,1146.9
May 29, 20264,715,950-5.5%993,5534.8
May 15, 20264,990,181-7.6%1,262,8954.0

Every measure, in full

87 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 3, 2027 (estimated, during market hours)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 16, 2026

Valuation ratiosIndustry

Market Cap
$159.04M
$261.21M
Enterprise Value
$89.53M
$135.05M
PE Ratio
16.75
23.48
PS Ratio
1.30
3.76
PB Ratio
1.91
2.00
P/TBV Ratio
2.04
2.22
P/OCF Ratio
32.58
13.21

Enterprise valuationIndustry

EV / Sales
0.73
2.44
EV / EBITDA
18.75
16.15
EV / EBIT
18.75
18.75

Share statisticsIndustry

Shares Change (YoY)
-1.97%
10.9%
Shares Change (QoQ)
0.15%
0.57%
Float
75M
49M
Shares Held by Insiders
5.07%
11.2%
Shares Held by Institutions
40.4%
56.2%

Short sellingIndustry

Short Interest
4M
–
Short Interest Change
4.16%
-0.81%
Short % of Float
5.79%
8.91%
Short % of Shares Outstanding
5.50%
6.30%
Days to Cover
8.91
5.16

Stock price statisticsIndustry

52-Week High
$7.12
–
52-Week Low
$1.97
–
20-Day Moving Average
$2.32
–
50-Day Moving Average
$2.64
–
200-Day Moving Average
$3.70
–
Average True Range (14)
$0.12
–
Price Change (1 Week)
-11.8%
-7.55%
Price Change (1 Month)
-19.3%
-4.88%
Price Change (3 Months)
-34.3%
-24.2%
Price Change (6 Months)
-45.7%
-21.7%
Price Change (YTD)
-68.4%
-26.2%
Price Change (1 Year)
-71.2%
-22.5%
Price Change (3 Years)
40.6%
-31.7%
Price Change (5 Years)
-65.2%
-78.2%
Price Change (10 Years)
-23.0%
-67.5%
Average Volume (10 Days)
617,584
–
Average Volume (20 Days)
553,422
–
Average Volume (90 Days)
572,337
–
Relative Volume
1.41
0.86
Relative Strength Index (14)
33.8
40.8
Volatility (1 Year)
50.6%
80.4%

MarginsIndustry

Gross Margin
63.9%
52.9%
Operating Margin
3.90%
-42.9%
Pretax Margin
9.04%
-13.0%
Profit Margin
8.37%
-39.9%
EBITDA Margin
3.90%
-30.2%

Returns on capitalIndustry

Return on Equity (ROE)
13.3%
-53.5%
Return on Assets (ROA)
9.90%
-40.7%
Return on Invested Capital (ROIC)
44.3%
-33.0%
Return on Capital Employed (ROCE)
5.20%
-38.7%

Financial positionIndustry

Current Ratio
5.93
3.30
Quick Ratio
4.52
2.39

GrowthIndustry

Revenue Growth (YoY)
-1.94%
5.71%
Net Income Growth (YoY)
-49.9%
-31.1%
EPS Growth (YoY)
-50.0%
-25.8%
Revenue Growth (3Y CAGR)
21.6%
2.25%
Revenue Growth (5Y CAGR)
16.9%
6.41%

EfficiencyIndustry

Asset Turnover
1.18
0.39
Inventory Turnover
2.25
2.68
Revenue Per Employee
$1.05M
$405.05K
Profits Per Employee
$87.52K
-$704.12K
Employee Count
117
75

Income statement (TTM)Industry

Revenue
$122.29M
$58.79M
Gross Profit
$78.10M
$103.58M
Operating Income
$4.78M
-$21.49M
Pretax Income
$11.06M
-$14.83M
Net Income
$10.24M
-$22.47M
EBITDA
$4.78M
-$17.14M
EPS (Diluted)
$0.12
-$0.83

Balance sheetIndustry

Net Cash (Debt)
$69.51M
$15.35M
Net Cash Per Share
$0.88
$0.71
Equity (Book Value)
$83.07M
$49.84M
Book Value Per Share
$1.05
$1.45
Tangible Book Value
$77.94M
$23.91M
Working Capital
$83.31M
$74.41M

Cash flow (TTM)Industry

Operating Cash Flow
$4.88M
-$12.17M

Dividends and yieldsIndustry

Earnings Yield
6.44%
-22.5%
Buyback Yield
3.38%
-0.65%
Shareholder Yield
3.38%
0.00%

Taxes and interestIndustry

Income Tax
$815.00K
$80.43K
Effective Tax Rate
7.37%
20.7%

Scores and fair valueIndustry

Graham Number
$1.68
$19.07
Graham Upside
-16.2%
-47.9%
Altman Z-Score
3.87
0.22
Piotroski F-Score
7
4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?